Company Overview

Development Stage

About the Company

[Summary] Adhering to the pursuit of high quality

Founded in 2000, Haisco Pharmaceutical Group is a listed pharmaceutical group company with new drug research and development as its core and particularly outstanding sales capabilities. It holds an important position in the segmented market of liver disease treatment, being one of the top production and sales bases for liver disease drugs in the country, with over 1,800 employees.\r\nThe company adheres to new product development as the core driving force for enterprise growth. After years of accumulation and practice, the company has established a research and development team of 450 people, including more than 50 doctors and nearly 100 masters. Over 95% of the team members have a bachelor's degree or above in pharmacy or related fields. The company's R&D team ranks at a leading level among domestic pharmaceutical enterprises in terms of technical expertise and team size, ranking third nationally in the number of new drug approvals obtained in the past five years.\r\nHaisco has strong technical capabilities. Currently, the scientific research work of the R&D center covers multiple clinical therapeutic areas, including parenteral nutrition, anti-tumor, cardiovascular, antiviral, endocrine, and central nervous system. The R&D center has independent buildings for generic drugs and innovative drugs, as well as pilot workshops and animal facilities, equipped with advanced and complete research facilities and instruments, reaching a leading level in new product development in the field of parenteral intravenous nutrition therapy. To date, the R&D center has completed the development of 51 new products for the company, with more than half being first generics launched, widely used in multiple therapeutic areas such as anti-infection, digestive system, blood system, nervous system, and parenteral nutrition. The company currently holds 30 authorized invention patents, 5 utility model patents, and 25 invention patents, with 161 registered trademarks.\r\nIn 2015, the company officially entered the high-end medical device market.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Haisco Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 深交所

Haisco How Fast Is Hiring Growing? (570 open positions)

Manage
Note: How fast is hiring at Haisco Pharmaceutical Group Joint-stock Co., Ltd. growing? Haisco2025: 897 openings (up 137%), 2024: 379 openings (down 29%), 2023: 531 openings (up 73%), 2022: 307 openings (down 73%), 2021: 1136 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Haisco Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at Haisco Pharmaceutical Group Joint-stock Co., Ltd. growing? HaiscoMaster's recruitment over the years: 2025: 122 openings (up 307%), 2024: 30 openings (down 71%), 2023: 104 openings (up 93%), 2022: 54 openings (up 69%), 2021: 32 openings.

Haisco Doctoral Degree Job Demand Analysis

(More)
+244%
Growth Rate
2026 vs 2025
  • 2025: Up 80%
  • 2024: Down 71%
  • 2023: Down 35%
  • 2022: Up 136%
Haisco Doctoral Hiring by Year: 2026 — 22 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Haisco Pharmaceutical Group Joint-stock Co., Ltd. growing? HaiscoDoctorate recruitment over the years: 2026: 31 openings (up 244%), 2025: 9 openings (up 80%), 2024: 5 openings (down 71%), 2023: 17 openings (down 35%), 2022: 26 openings (up 136%), 2021: 11 openings.

Haisco R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Haisco Pharmaceutical Group Joint-stock Co., Ltd.? Based on an analysis of Haisco's job postings over the past year, "医疗卫生/美容保健类" demand: 30%, "生物/制药/化工/环保类": 18.5%, "计算机/网络/技术类": 10%, "其他(研发和技术类)": 4.3%, "科研类": 4.1%, "机械/仪器仪表类": 1.1%. For reference only.

Haisco — What Are the Salaries Like? (1754 records)

Manage
salary range: 6K - 50K, 77.2% of roles pay ¥10-50K
Note: salary statistics are based on 1754 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Haisco Pharmaceutical Group Joint-stock Co., Ltd.?Haisco77.2% of positions earn 10-50K, Fresh graduate salary: ¥15.9K。Chengdu salary ranking top 35,销售类 average salary ¥20.2K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Haisco

(More)
Are salaries high at Haisco Pharmaceutical Group Joint-stock Co., Ltd.? We provide: 医药代表,临床,信息,ra,地区经理,副总,销售,研究员,分析,医学经理,大区经理,项目经理,pm,ka,产品经理,学术经理,监察,质量,麻醉,msl. Click to view detailed salary analysis by job.

Haisco — Fortune 500? (More)

Haisco honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Haisco Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 销售类
    48.7% of total 48.7%
  • 医疗卫生/美容保健类
    30% of total 30%
  • 经营管理类
    23.8% of total 23.8%
  • 生物/制药/化工/环保类
    18.6% of total 18.6%

Education

  • 本科
    42.9% of total 42.9%
  • 大专
    34.8% of total 34.8%
  • 硕士
    17.4% of total 17.4%
  • 博士
    2.2% of total 2.2%

Experience

  • 1-3年
    35.4% of total 35.4%
  • 5-10年
    22.8% of total 22.8%
  • 3-5年
    21.3% of total 21.3%
  • 不限
    20% of total 20%
View Detailed Analysis

What does Haisco Pharmaceutical Group Joint-stock Co., Ltd. require? Who is Haisco hiring? Haisco recruitment: 销售类占比最多占48.7%,其次是医疗卫生/美容保健类占30%. What education can get in at Haisco? 本科占比最多占42.9%,其次是大专占34.8%. High education required at Haisco? 硕士占17.4%,博士占2.2%. Work experience required at Haisco? 1-3年占比最多占35.4%,其次是5-10年占22.8%. Where are the job locations at Haisco? 上海占比最多占18.6%,其次是成都占17.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 111,991.797万(元)
Legal Representative: 严庞科
Date Established:
Credit Code: 91542200741928586E
Registered Address: 西藏山南市泽当镇三湘大道17号

Partners & Suppliers

提供原料药及中间体研发生产服务 Source
供应商 制药/API合作
向泓博医药采购药物研发服务(CRO)及工艺研发服务(CDMO) Source
供应商 制药企业
2022年,海思科与圆心科技签署战略合作协议,在创新药DTP专业药房、患者教育和管理等领域合作,由圆心科技销售海思科产品。 Source
合作客户 DTP专业药房
2022年3月,海思科与博腾股份签署战略合作框架协议,由博腾股份作为CDMO为海思科提供原料药及制剂生产服务。 Source
供应商 药物研发外包服务(CRO/CDMO)
2022年,海思科与全球健康药物研发中心(GHDDI,注册名:北京华益健康药物研究所有限公司)合作开发抗新冠病毒药物,海思科提供研发资金。 Source
供应商 学术及临床合作

People who follow Haisco also follow

Haisco Competitors (Similar Companies)

“Let everyone have trust and expectation in Baili because of health!”
“Professional manufacturer and operator of large-volume parenteral solu”
V
“Health for all, vitality for life!”
医药 生物医药 单克隆抗体药物 高通量筛选
“A pharmaceutical group committed to the research, development, product”
医药流通 生产 医药配送 销售
“For a Better Life”
制药/药业 医药 新药研发 肠外营养
“A comprehensive pharmaceutical enterprise integrating drug R&D, produc”
“Benefit farmers, nourish consumers”
医药 生物制品 化学制药 药物研发
“成为绿色化学领域的世界品牌企业”
“Research, development, and production of anti-tumor and surgical medic”
医药科技 医药 医药工业 临床医学
“Council member of China Condiment Industry Association, national key l”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates